Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 10, 2000, Pages 3107-3116

  Ikuno, Y ^a   Leong, F L ^a   Kazlauskas, A ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; MOUSE; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; SITE DIRECTED MUTAGENESIS; VITREORETINOPATHY;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; MICE; MUTAGENESIS, SITE-DIRECTED; PLATELET-DERIVED GROWTH FACTOR; POINT MUTATION; POLYMERASE CHAIN REACTION; RABBITS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RETROVIRIDAE; TRANSFECTION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 0033828125     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Proliferative vitreoretinopathy: An overview
2. Proliferative vitreoretinopathy
3. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye
4. Expression of vitreous cytokines in proliferative vitreoretinopathy: A prospective study
5. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases
6. Platelet-derived growth factor is chemotactic for human retinal pigment epithelial cells
7. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells
8. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders
9. Porcine model of proliferative vitreoretinopathy with platelets
10. Hepatocyte growth factor receptor in human RPE cells: Implications in proliferative vitreoretinopathy
11. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy
12. Primary structure of c-kit Relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus
13. c-kit Protein, a transmembrane kinase: Identification in tissues and characterization
14. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors
15. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus W37, Wv, W41 and W
16. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase
17. Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: A description of ten new W alleles
18. PDGF signalling is required for gastrulation of Xenopus laevis
19. Inhibition of PDGF beta receptor signal transduction by coexpression of a truncated receptor
20. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy
21. Platelet-derived growth factor-dependent cellular transformation requires either phospholipase Cγ or phosphatidylinositol 3 kinase
22. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation
23. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes
24. Protein kinase C mediates platelet-derived growth factor-induced tyrosine phosphorylation of p42
25. The role of cellular proliferation in an experimental model of massive periretinal proliferation
26. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation
27. Dominant-negative mutations of platelet-derived growth factor (PDGF) receptors. Inhibition of receptor function by ligand-dependent formation of heterodimers between PDGF alpha- and beta-receptors
28. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
29. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism
30. TGF-beta induces bimodal proliferation of connective tissue ceils via complex control of an autocrine PDGF loop
31. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta
32. Platelet-derived growth factor is a cofactor in the induction of 1 alpha(I) procollagen expression by transforming growth factor-beta 1 in smooth muscle cells
33. Matrix protein synthesis by glomerular mesangial cells in culture: Effects of transforming growth factor beta (TGF beta) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA
34. Regulation of fibroblast-mediated collagen gel contraction by platelet-derived growth factor, interleukin-1 alpha and transforming growth factor-beta 1
35. Additive effects of extra cellular matrix proteins and platelet derived mitogens on human retinal pigment epithelial cell proliferation and contraction
36. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial ceils leads to contraction of collagen gels
37. Retinal pigment epithelial cells: Autocrine and paracrine stimulation of extracellular matrix contraction
38. Src family kinases negatively regulate platelet-derived growth factor alpha receptor-dependent signaling and disease progression
39. Role of platelet-derived growth factor in renal injury
40. Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes
41. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
42. A novel monoclonal antibody dependent on domain 5 of the platelet-derived growth factor beta receptor inhibits ligand binding and receptor activation
43. Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts
44. Identification of a peptide antagonist for platelet-derived growth factor
45. An antibody reactive with domain 4 of the platelet-derived growth factor beta receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization
46. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation